EU Fines Teva, Cephalon For Pay-for-delay Drug Deal
By Baud486 in Business
Updated 3 years ago
The European Commission has fined pharmaceutical company Teva and its now subsidiary Cephalon 60.5 million euros ($72 million) for agreeing to delay a cheaper generic version of Cephalon's sleep disorder medicine.
